Carregant...
Carregant...

Vés al contingut (premeu Retorn)

Tumor targeting via integrin ligands

Autor
Marelli, U.K.; Rechenmacher, F.; Sobahi, T.R.A.; Mas-Moruno, C.; Kessler, H.
Tipus d'activitat
Article en revista
Revista
Frontiers in Oncology
Data de publicació
2013
Volum
2013
Número
00222
DOI
https://doi.org/10.3389/fonc.2013.00222 Obrir en finestra nova
Repositori
http://hdl.handle.net/2117/22780 Obrir en finestra nova
Resum
Selective and targeted delivery of drugs to tumors is a major challenge for an effective cancer therapy and also to overcome the side-effects associated with current treatments. Overexpression of various receptors on tumor cells is a characteristic structural and biochemical aspect of tumors and distinguishes them from physiologically normal cells. This abnormal feature is therefore suitable for selectively directing anticancer molecules to tumors by using ligands that can preferentially recogni...
Citació
Marelli, U.K. [et al.]. Tumor targeting via integrin ligands. "Frontiers in Oncology", 2013, vol. 2013, núm. 00222.
Grup de recerca
CRnE - Centre de Recerca en Ciència i Enginyeria Multiescala de Barcelona

Participants

  • Marelli, Udaya Kiran  (autor)
  • Rechenmacher, Florian  (autor)
  • Sobahi, Tariq Rashad Ali  (autor)
  • Mas Moruno, Carlos  (autor)
  • Kessler, Horst  (autor)

Arxius